C07C311/28 - CPC Classification Index

ClassID:

93442 ⎘

C07C311/28 - CPC Classification

Classification description:

Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring

Recent Application in this class:

20180064665

2018-03-08

N-PHENYL-N'-PHENOXYCARBONYL-PHENYLSULFONHYDRAZIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

20170183333

2017-06-29

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

20160206578

2016-07-21

Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use

20150266815

2015-09-24

Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use

20150051256

2015-02-19

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

20140378466

2014-12-25

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

20140303253

2014-10-09

Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof

20140011130

2014-01-09

Polymerizable monomer, polymeric compound, charge control agent containing the polymeric compound, and developer bearing member and toner which contain the charge control agent

20130345304

2013-12-26

Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent

#10

20130046000

2013-02-21

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

#11

20120302518

2012-11-29

Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof

#12

20120269803

2012-10-25

SUBSTITUTED BENZOSULPHONAMIDES

#13

20120178946

2012-07-12

Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-3,4-difluoro-2(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide

#14

20120022076

2012-01-26

Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK

#15

20120016034

2012-01-19

Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof

#16

20110172189

2011-07-14

Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use

#17

20090227681

2009-09-10

Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof

#18

20090082457

2009-03-26

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#19

20080058340

2008-03-06

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK